HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $21,000 | +5.0% | 878 | -18.5% | 0.00% | – |
| Q3 2019 | $20,000 | +100.0% | 1,077 | +111.6% | 0.00% | – |
| Q2 2019 | $10,000 | -71.4% | 509 | -64.1% | 0.00% | – |
| Q1 2019 | $35,000 | +84.2% | 1,416 | +96.4% | 0.00% | – |
| Q4 2018 | $19,000 | +137.5% | 721 | +185.0% | 0.00% | – |
| Q3 2018 | $8,000 | -20.0% | 253 | +2.8% | 0.00% | – |
| Q2 2018 | $10,000 | +42.9% | 246 | -2.0% | 0.00% | – |
| Q1 2018 | $7,000 | +600.0% | 251 | +434.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 47 | +20.5% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 39 | -32.8% | 0.00% | – |
| Q3 2016 | $1,000 | – | 58 | +205.3% | 0.00% | – |
| Q2 2016 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |